Literature DB >> 23944035

[Analysis of alkaloids in Zanthoxylum nitidum by HPLC-DAD/ESI-Q-TOF-MS].

Chang-Ping Jia1, Xue-Li Huang, Yun Li, Fang Feng.   

Abstract

The alkaloids in Zanthoxylum nitidum were identified by HPLC-DAD/ESI-Q-TOF-MS. Separation was performed on a Hanbon C18 column with acetonitrile (with 0.1% formic acid) and water(with 0.1% formic acid) as mobile phase. Based on the high-resolution mass information, MS/MS fragmentation behaviors and chemical components from literatures, 48 components were identified or tentatively characterized including 6 new compounds. This work could be useful for the quality control and further studies of the plant.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23944035

Source DB:  PubMed          Journal:  Zhongguo Zhong Yao Za Zhi        ISSN: 1001-5302


  4 in total

1.  Inhibitors Targeting Multiple Janus Kinases From Zanthoxylum simulans Mediate Inhibition and Apoptosis Against Gastric Cancer Cells via the Estrogen Pathway.

Authors:  Yong-Qiang Tian; Dai Hu; Yong-Li Zhang; Jian Zou; Gui-Lin Chen; Ming-Quan Guo
Journal:  Front Chem       Date:  2022-06-06       Impact factor: 5.545

2.  Profiling and Pharmacokinetic Studies of Alkaloids in Rats After Oral Administration of Zanthoxylum nitidum Decoction by UPLC-Q-TOF-MS/MS and HPLC-MS/MS.

Authors:  Aihua Huang; Yuguang Chi; Jiawei Liu; Mincun Wang; Jialiang Qin; Lijuan Ou; Weiwen Chen; Zhongxiang Zhao; Ruoting Zhan; Hui Xu
Journal:  Molecules       Date:  2019-02-07       Impact factor: 4.411

3.  Spectrum-Effect Relationship Analysis of Bioactive Compounds in Zanthoxylum nitidum (Roxb.) DC. by Ultra-High Performance Liquid Chromatography Mass Spectrometry Coupled With Comprehensive Filtering Approaches.

Authors:  Si-Wei Rao; Yuan-Yuan Duan; Han-Qing Pang; Shao-Hua Xu; Shou-Qian Hu; Ke-Guang Cheng; Dong Liang; Wei Shi
Journal:  Front Pharmacol       Date:  2022-03-09       Impact factor: 5.810

4.  Comparative study on alkaloids and their anti-proliferative activities from three Zanthoxylum species.

Authors:  Yongqiang Tian; Chunyun Zhang; Mingquan Guo
Journal:  BMC Complement Altern Med       Date:  2017-09-12       Impact factor: 3.659

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.